2021
DOI: 10.1016/j.jped.2021.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of serum and salivary C-reactive protein for diagnosis of late-onset neonatal sepsis: A single center cross-sectional study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
7
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 27 publications
2
7
0
Order By: Relevance
“…Our study revealed a significant difference between septic and control neonates. In agreement with our results, other researchers observed the same findings [3,[15][16][17]. Also, salivary CRP was investigated as a noninvasive marker for the diagnosis of neonatal sepsis [15][16][17].…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…Our study revealed a significant difference between septic and control neonates. In agreement with our results, other researchers observed the same findings [3,[15][16][17]. Also, salivary CRP was investigated as a noninvasive marker for the diagnosis of neonatal sepsis [15][16][17].…”
Section: Discussionsupporting
confidence: 92%
“…Saliva is an excellent noninvasive and easily accessible biofluid that represents an alternative to serum testing to assess and monitor critically ill neonates. Salivary biomarkers were reported to detect infections in full-term and preterm infants [13][14][15][16][17][18].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our results agree with previous reports. [36][37][38] Moreover, a recent meta-analysis that included six studies conducted on patients with LOS with varying gestational ages concluded that the pooled sensitivity and specificity of CRP for LOS diagnosis were 71.7 and 76.1%, respectively. 39 In contrast, the systematic review by Brown et al reported that serum CRP level is insufficiently accurate to aid early diagnosis or antimicrobial therapy of infants with suspected LOS.…”
Section: Discussionmentioning
confidence: 99%
“…This makes saliva as a potentially useful diagnostic biofluid for disease detection and monitoring in neonates. Saliva has been studied as an alternative biological fluid suitable for a noninvasive diagnostic and follow-up tool in neonatal infections including salivary CRP in the diagnosis of neonatal sepsis and pneumonia [19,20,[38][39][40][41] and screening of neonatal cytomegalovirus by salivary real-time PCR [42].…”
Section: Discussionmentioning
confidence: 99%